After years of medical issues, columnist G Shellye Horowitz has acquired numerous assistive devices, which come in handy ...

As columnist Mary Shaniqua looks to the future, she remembers when she was far more active — and wonders if that could be a ...

Columnist Alliah Czarielle doesn't want a person with an invisible disability to be perceived by businesses as a fraud.

In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...

IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with ALS in a Phase 2 clinical trial.

Columnist Sam Kirton has spent years finding calm through a popular British phrase, which has allowed him to carry on through medical crises.

The director believes the icon himself wanted to better understand the period in his life depicted in the film, especially ...

Canaccord analyst Joseph Vafi lowered the firm’s price target on Strategy (MSTR) to $409 from $510 and keeps a Buy rating on the shares. The ...

Looking for an online ALS group? Columnist Dagmar Munn has you covered with helpful tips gleaned from years as a forums co-moderator.

Duchenne muscular dystrophy (DMD) treatment ifetroban led to improvements in measures of heart function in a Phase 2 clinical ...

In our first episode back after the Oscar nominations, we chat with 'Nickel Boys' filmmaker RaMell Ross and costume designer ...